L&L Products Announces New InsituCore™ Foaming Materials for Composite Manufacturing
L&L Products announces the launch of its proprietary InsituCore™ foaming materials for lightweight composite manufacturing. These new materials enable simplified production processes, resulting in a final lightweight net-shape part or preform with targeted density and strength.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905955948/en/
InsituCore™ (Photo: Business Wire)
InsituCore™ Foaming Core Technology is a family of one-component, heat-activated foaming materials that generate internal pressure to create lightweight and strong net shape, 3D parts in a simple, clean, and cost-effective process.
Placed in a heated tool, the InsituCore™ material foams to fill the mold cavity and form net-shape parts without time-consuming machining processes or autoclave equipment. Compared to traditional manufacturing and machining methods such as liquid resin layups, split molding, and bladder molding, these materials enable faster cycle times, a reduction in waste material, and optimized production processes by eliminating secondary machining and assembly operations.
“InsituCore™ is an ideal alternative to traditional manufacturing and machining methods that have long gone unchanged,” said Blake Synnestvedt, Director of Business Development at L&L Products North America. “The composites industry has been due for an innovative solution that cuts down on waste and improves process times, and InsituCore™ is that product. As it becomes more widely used and field-tested, we look forward to helping customers leverage all the benefits of InsituCore™ to meet their unique needs.”
Potential applications include sporting goods, aircraft tray tables, insulated panels, automotive OEM and aftermarket parts.
As part of the launch, L&L Products introduces its first two commercial products: InsituCore™ L-9008 is a one-component, heat-activated, thermosetting foam material that can be used to create foam core composites.
InsituCore™ L-9080 is a one-component, heat-activated, thermoplastic foam material that can be used to create foam core composites.
For more information on InsituCore™, visit InsituCore.llproducts.com.
About L&L Products
L&L Products combines expertise in materials science, advanced engineering, and manufacturing process optimization for customers to develop unique solutions that deliver structural reinforcement, substrate bonding, static sealing, and acoustic improvement for automotive, aerospace, commercial vehicle, construction, and consumer products applications. For nearly 70 years, our skilled chemists, scientists, and engineers have collaborated with customers around the world to make products lighter, stronger, and quieter. Today, L&L has over 1200 employees worldwide, 10 manufacturing facilities, and locations in 15 countries. For more information, visit www.llproducts.com.
Links
InsituCore.llproducts.com
www.llproducts.com
http://www.llproducts.com/news/
https://www.linkedin.com/company/l&l-products
View source version on businesswire.com: https://www.businesswire.com/news/home/20240905955948/en/
Contacts
Kyle Cronin
Kyle Cronin
Airfoil for L&L Products
llproducts@airfoilgroup.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Decent Cybersecurity to Showcase Post-Quantum Solutions at DSEI Japan 202516.5.2025 09:49:00 CEST | Press release
Decent Cybersecurity announces its participation at DSEI Japan 2025 as the only Slovak cybersecurity company exhibiting at this premier defense event in Makuhari Messe, Chiba (May 21-23, 2025). The company will showcase its advanced post-quantum security solutions for aerospace, defense, and space sectors, including SpaceShield STM, DroneCrypt UTM, and QuantumProof Protocol. "The Indo-Pacific region represents a critical frontier for post-quantum cybersecurity innovation as quantum computing advances threaten traditional encryption," said Matej Michalko, Founder, Chairman and CEO of Decent Cybersecurity. "Our participation demonstrates our commitment to offering Japanese defense and space agencies access to European-certified, quantum-resistant security solutions that protect critical infrastructure against emerging threats." As a holder of NATO, EU, and national security clearances at the "Secret" level, Decent Cybersecurity brings unique post-quantum security credentials to the Japan
LTIMindtree, Eurobank and Fairfax Digital Services Collaborate to Build Digital Innovation Hub in Cyprus16.5.2025 09:00:00 CEST | Press release
This center will facilitate the development of Advanced Digital Solutions for Eurobank, Fairfax and other EU customers. LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced the opening of its Digital Innovation Hub at the Research and Innovation Hub of CYENS Center of Excellence. The LTIMindtree Digital Innovation Hub will enable ideation, co-creation and implementation of Advanced Digital Solutions for Eurobank, Fairfax and other EU customers and aligns with the strategic vision of the Cyprus Government to strengthen Cyprus’ role as a regional tech and innovation hub, triggering unique cross-border opportunities for tech collaborations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515054331/en/ Srini Rao EVP & Chief Business Officer- Europe, LTIMindtree | Mr. Nikodemos Damianou, Deputy Minister of Research and Innovation, Govt of Cyprus | Mr. Fokion Karavias,
ROYC Acts as the Structuring and Financial Technology Partner for Riverside for European Wealth Access Fund16.5.2025 08:30:00 CEST | Press release
ROYC, the leading provider of complete private markets operating systems, announces the structuring of a new access fund for Private Wealth launched in collaboration with The Riverside Company. The Riverside Company is a global private equity firm focused on investing in growing businesses valued at up to $400 million. Since its founding in 1988, Riverside has made more than 1,000 investments and today has over $12 billion in assets under management. The firm's international private equity and structured capital portfolios include more than 140 companies. The Riverside’s proven investment strategy of acquiring and developing high-potential European SMEs in resilient, growth-oriented sectors, including technology and software, healthcare, advanced manufacturing and consumer products. “This fund represents a unique opportunity for wealth investors to access value creation generally reserved for institutional investors,” says Karsten Langer, Managing Partner at Riverside Europe and contin
Rimini Street Announces Upcoming 2025 Investor Conference Schedule15.5.2025 22:51:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced that Michael L. Perica, chief financial officer, and Dean Pohl, vice president, treasurer and investor relations, will be presenting and meeting with investors one-on-one and in small group meetings at the following conferences: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250515374696/en/ Rimini Street Announces Upcoming 2025 Investor Conference Schedule May 28, 2025: Craig-Hallum 22nd Annual Institutional Investor Conference, Minneapolis May 29, 2025: TD Cowen 53rd Annual TMT Conference, New York City Fireside Chat: 1:15 pm Eastern, webcast link June 24-26, 2025: Roth 15th Annual London Conference, London To schedule a meeting please contact your salesperson or Rimini Street Investor Relations at IR@rimin
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States15.5.2025 20:30:00 CEST | Press release
Zynyz® (retifanlimab-dlwr), a PD-1 inhibitor, is now approved for the treatment of advanced squamous cell carcinoma of the anal canal (SCAC) in combination with chemotherapy and as a monotherapyPatients with SCAC treated with Zynyz achieved a statistically significant improvement in progression-free survival and improvement in overall survival Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Zynyz® (retifanlimab-dlwr), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC). In addition, the FDA granted approval for Zynyz as a single agent for the treatment of adult patients with locally recurrent or with metastatic SCAC with disease progression on or intolerance to platinum-based chemotherapy. Thi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom